Prasugrel/Clopidogrel Maintenance Dose Washout Study
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to describe the cumulative proportion of participants
who return to baseline platelet P2Y12 receptor function over time (up to 12 days post last
maintenance dose) following discontinuation of prasugrel 10 mg daily x 7 days assessed by
Accumetrics VerifyNow P2Y12 reaction units (PRU) and described by Kaplan Meier curves. The
primary analysis is descriptive and is intended to provide information relating to the return
of baseline platelet function following discontinuation of maintenance therapy with either
prasugrel or clopidogrel.